Explorer
Debate: Experts share key points after vaccine approval
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
India
Big Breaking: Kanpur Road Rage Turns Deadly, Father and Son Killed
View More
Top Headlines
India
Marco Rubio, Wife Jeanette Visit Taj Mahal During Agra Visit: WATCH
India
Divorced Daughter Better Than Dead Daughter, Says SG As SC Hears Twisha Sharma Case
India
'Silent Tax On Every Household’: Congress Targets Modi Govt Over Fuel Price Hike
India
From Meme To Movement? Cockroach Janta Party Lays Out Political Vision
